Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | > 790.5 uM | Cytotoxic concentration required to inhibit CEM cell proliferation by 50%. | ChEMBL. | 7658442 |
CC50 (functional) | > 790.5 uM | Cytotoxic concentration required to inhibit CEM cell proliferation by 50%. | ChEMBL. | 7658442 |
IC50 (functional) | = 395.3 uM | Inhibitory concentration against respiratory syncytial virus in HeLa cells | ChEMBL. | 7658442 |
IC50 (functional) | = 395.3 uM | Inhibitory concentration against respiratory syncytial virus in HeLa cells | ChEMBL. | 7658442 |
IC50 (functional) | > 790.5 uM | Inhibitory concentration against influenza virus A in MDCK cells | ChEMBL. | 7658442 |
IC50 (functional) | > 790.5 uM | Inhibitory concentration against influenza virus B in MDCK cells | ChEMBL. | 7658442 |
IC50 (functional) | > 790.5 uM | Inhibitory concentration against parainfluenza-3 virus in vero cells | ChEMBL. | 7658442 |
MTC (ADMET) | > 790.5 uM | Minimum toxic concentration required to cause a microscopically detectable alteration of normal MDCK cell morphology | ChEMBL. | 7658442 |
MTC (ADMET) | > 790.5 uM | Minimum toxic concentration required to cause a microscopically detectable alteration of normal HeLa cell morphology | ChEMBL. | 7658442 |
MTC (ADMET) | > 790.5 uM | Minimum toxic concentration required to cause a microscopically detectable alteration of normal vero cell morphology | ChEMBL. | 7658442 |
MTC (ADMET) | > 790.5 uM | Minimum toxic concentration required to cause a microscopically detectable alteration of normal HeLa cell morphology | ChEMBL. | 7658442 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.